statistiche ricercatore

Continente	#
NA - Nord America	1.827
AS - Asia	568
EU - Europa	540
SA - Sud America	70
AF - Africa	9
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	3.017

Nazione	#
US - Stati Uniti d'America	1.818
SG - Singapore	217
GB - Regno Unito	158
CN - Cina	154
IT - Italia	111
SE - Svezia	72
HK - Hong Kong	70
BR - Brasile	57
DE - Germania	56
RU - Federazione Russa	36
UA - Ucraina	36
VN - Vietnam	36
TR - Turchia	25
IN - India	17
ID - Indonesia	15
BG - Bulgaria	14
FI - Finlandia	14
FR - Francia	12
JP - Giappone	8
NL - Olanda	7
KR - Corea	6
CA - Canada	5
IE - Irlanda	5
AR - Argentina	4
EC - Ecuador	4
EG - Egitto	4
IR - Iran	4
AT - Austria	3
CZ - Repubblica Ceca	3
PH - Filippine	3
AU - Australia	2
BD - Bangladesh	2
BE - Belgio	2
CL - Cile	2
CO - Colombia	2
ES - Italia	2
LT - Lituania	2
MX - Messico	2
MY - Malesia	2
PL - Polonia	2
TW - Taiwan	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
EU - Europa	1
GR - Grecia	1
HU - Ungheria	1
IL - Israele	1
JO - Giordania	1
KE - Kenya	1
LI - Liechtenstein	1
LV - Lettonia	1
MA - Marocco	1
NP - Nepal	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
SK - Slovacchia (Repubblica Slovacca)	1
TL - Timor Orientale	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
Totale	3.017

Nome	#
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study	288
How Much Does AMH Really Vary in Normal Women?	271
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period	266
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count	265
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization	260
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period	254
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study	247
How to personalize ovarian stimulation in clinical practice	228
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception	220
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history	216
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study	211
Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers	170
Ovarian reserve markers to identify poor responders in the context of poseidon classification	159
Totale	3.055

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	214	0	0	0	0	0	23	39	53	14	35	32	18
2021/2022	284	7	12	46	19	10	14	17	20	25	20	60	34
2022/2023	317	25	46	26	50	40	34	5	27	34	2	10	18
2023/2024	173	7	9	2	25	23	1	29	28	6	4	8	31
2024/2025	510	15	8	5	34	113	69	24	42	83	21	44	52
2025/2026	435	58	23	71	86	147	50	0	0	0	0	0	0
Totale													3.055